NutraNomics Inc (OTCMKTS:NNRX) Stock On radar After Record August 2022 New Sales Bookings

Emerging leader in organic plant-based nutritional science and innovation, NutraNomics Inc (OTCMKTS:NNRX) on September 6, 2022, announced that the Plant, NutraNomics company, generated fresh August sales bookings of $505,463. This is higher than the monthly average of $335,000, demonstrating the highest single-month new sales production in its history.

Trading Data

On Tuesday, NNRX stock ended flat at $0.0003 with more than 24.44 million shares, compared to its average volume of 96.95 million shares. The stock moved within a range of $0.0002 – 0.0003 after opening trading at $0.0003.

NutraNomics, Inc. and The Plant Announce Record August 2022 New Sales Bookings

The firm’s sales strategy gives importance to diversifying its buyer base by forming robust customer relationships as well as the acquisition of customers consistently.

Geoff Bazegian, NutraNomics’ President and CRO said that sales for the first two months of quarter three have matched the highest revenue quarter witnessed by the firm. The third quarter is projected to be a record revenue quarter. Bazegain also said that the company feels that it is proof of the strategy of quality, price competitiveness as well as professionalism fueling growth in the future.

The sales achievement is important as August has historically been a low month for the California Cannabis dispensary market. Customers are liquidating existing inventories during this time preparing for holiday shelf restocking into the last quarter of the year.

The firm’s investments in innovation and technology are leading to optimizing efficiency and higher sales. Nutranomics will be adding extra seasoned sales personnel in September, a densely concentrated region of buyers in the California Cannabis market.

Key Quote

“Sales for the first 2 months of Q3 have already matched the highest revenue quarter the Company has ever seen. As such, Q3 is projected to be a record revenue quarter for the Company”, remarked Geoff Bazegian, NutraNomics’ President and CRO. “We feel this is clear proof that our strategy of quality, price competitiveness and professionalism will continue to fuel our goal of steady and consistent growth into the future.”